动态对比增强前列腺多参数MRI上的包膜强化征对检测包膜外侵犯的价值
本研究回顾性纳入146例根治性前列腺切除术前接受多参数MRI的患者,评估包膜强化征(CES)预测前列腺癌包膜外侵犯(ECE)的效能。两位泌尿放射科医师独立及共识判读,CES组间一致性PABAK为0.90;共识判读15/146(10%)阳性,所有CES阳性病灶均为病理分期≥T3a,CES对ECE特异度和PPV均为100%,但敏感度仅16.5%、NPV 41.3%、准确率47.4%。作者认为CES罕见但高度特异,可能改善显示该征象患者的局部分期。
要点
- CES定义为DCE-MRI上邻近外周带肿瘤的非对称早期高强化区,范围匹配或超过肿瘤周径且持续强化。
- 共识判读CES阳性15/146(10%),在病理证实ECE的肿瘤中占15/91(17%)。
- CES对ECE特异度和PPV均为100%,敏感度16.5%、NPV 41.3%、准确率47.4%。
核心结论
- CES是mpMRI上罕见但高度特异的ECE预测征象,可能改善显示该征象患者的局部分期。
研究设计与样本
- 回顾性研究,纳入146例根治性前列腺切除术前接受mpMRI的患者,由两位泌尿放射科医师独立及共识判读CES,以手术病理为参考标准,组间一致性采用PABAK评估。
关键影像表现/征象
- CES表现为DCE-MRI上邻近外周带肿瘤的非对称早期高强化区,范围匹配或超过肿瘤周径,且呈持续强化。
- 共识判读确定的CES阳性病灶均对应病理分期≥T3a。
诊断标准与关键数值
- CES对ECE检测的特异度100%、PPV 100%。
- CES对ECE检测的敏感度16.5%、NPV 41.3%、准确率47.4%。
- 两位读者间CES判读一致性PABAK为0.90。
临床应用与阅片要点
- 阅片时需在DCE-MRI上关注邻近外周带肿瘤的非对称早期高强化且持续强化区,范围需匹配或超过肿瘤周径。
- CES阳性提示ECE可能,但该征象敏感度低,阴性不能排除ECE。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
PURPOSE: To retrospectively determine the prevalence and diagnostic performance of the capsular enhancement sign (CES) on multiparametric (mp) MRI for the detection of prostate cancer (PCa) extracapsular extension (ECE).
METHODS: This retrospective study included patients who underwent mpMRI prior to radical prostatectomy. CES was defined as an area of asymmetrical early hyperenhancement on DCE-MRI adjacent to a peripheral zone tumour, matched or exceeded the tumour circumferential diameter, and with persistent enhancement. Two uro-radiologists evaluated the presence of CES on mpMRI, independently and in consensus, with interobserver agreement calculated using bias and prevalence-adjusted kappa (PABAK). CES performance for predicting ECE was assessed using sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV).
RESULTS: The study included 146 patients, with 91/146 (62%) having ECE on surgical pathology. Following initial review, Reader 1 identified 12/146 (8%) CES-positive cases, while Reader 2 reported 14/146 (10%) CES-positive cases, with 15/146 (10%) lesions determined as demonstrating the CES sign on consensus reading. PABAK for CES between the two readers was high at 0.90. All consensus determined CES-positive lesions represented pathological stage ≥ T3a disease, with the overall prevalence of CES among tumours with confirmed ECE being 15/91 (17%). The sign showed high specificity (100%) and PPV (100%) for ECE detection, but with low sensitivity, NPV, and accuracy at 16.5%, 41.3%, and 47.4%, respectively.
CONCLUSIONS: CES was demonstrated to be a rare but highly specific ECE predictor on mpMRI that may improve local staging in the patients in whom it is demonstrated.
引用
- Caglic, Sushentsev, Colarieti, et al. Value of the capsular enhancement sign on dynamic contrast-enhanced prostate multiparametric MRI for the detection of extracapsular extension. Eur J Radiol. 2022. PMID: 35358786. doi:10.1016/j.ejrad.2022.110275
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。